AK
Insider
Andrew T. Kaplan
DirectorAndrew T. Kaplan (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in KLRA. Across 1 priced purchase filing, the average 21-session return was -26.2% from execution and -26.2% from disclosure (delay-adjusted; derived). The largest single filing was $134.4M of KLRA (8,398,438 sh × $16.00, as filed), executed Apr 20.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-26.2%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-26.2%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$134.4M
shares × price, as filed
Last traded
Apr 20
Filed Apr 20
Volume by month
Buys $134.4M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 12 months
Most traded names
KLRA
KLRA
KLRA · 1 buy · 0 sells
1 filing
Recent filings
KLRAPURCHASE
Kailera Therapeutics, Inc.
View filing →
$134.4M8,398,438 sh × $16.00
Exec Apr 20
Filed Apr 20 · 6:00 PM ET